[go: up one dir, main page]

GB0700759D0 - Novel fusion protein - Google Patents

Novel fusion protein

Info

Publication number
GB0700759D0
GB0700759D0 GB0700759A GB0700759A GB0700759D0 GB 0700759 D0 GB0700759 D0 GB 0700759D0 GB 0700759 A GB0700759 A GB 0700759A GB 0700759 A GB0700759 A GB 0700759A GB 0700759 D0 GB0700759 D0 GB 0700759D0
Authority
GB
United Kingdom
Prior art keywords
fusion protein
novel fusion
novel
protein
fusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0700759A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GB0700759A priority Critical patent/GB0700759D0/en
Publication of GB0700759D0 publication Critical patent/GB0700759D0/en
Priority to EA200900738A priority patent/EA016818B1/en
Priority to PCT/US2008/050879 priority patent/WO2008089074A2/en
Priority to EP08727588A priority patent/EP2118128B1/en
Priority to DK08727588.9T priority patent/DK2118128T3/en
Priority to BRPI0806501-2A2A priority patent/BRPI0806501A2/en
Priority to PL08727588T priority patent/PL2118128T3/en
Priority to HRP20130022AT priority patent/HRP20130022T1/en
Priority to ES08727588T priority patent/ES2398492T3/en
Priority to PE2008000128A priority patent/PE20081687A1/en
Priority to KR1020097016892A priority patent/KR20090122426A/en
Priority to CA002674458A priority patent/CA2674458A1/en
Priority to MX2009007572A priority patent/MX2009007572A/en
Priority to PT87275889T priority patent/PT2118128E/en
Priority to TW097101220A priority patent/TW200902049A/en
Priority to AU2008206463A priority patent/AU2008206463B2/en
Priority to CNA2008800022234A priority patent/CN101583623A/en
Priority to JP2009545705A priority patent/JP2010532656A/en
Priority to SI200830870T priority patent/SI2118128T1/en
Priority to ARP080100128A priority patent/AR064863A1/en
Priority to CL200800103A priority patent/CL2008000103A1/en
Priority to US12/503,468 priority patent/US8309096B2/en
Priority to CY20131100042T priority patent/CY1113720T1/en
Ceased legal-status Critical Current

Links

GB0700759A 2007-01-15 2007-01-15 Novel fusion protein Ceased GB0700759D0 (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
GB0700759A GB0700759D0 (en) 2007-01-15 2007-01-15 Novel fusion protein
ARP080100128A AR064863A1 (en) 2007-01-15 2008-01-11 FUSION PROTEIN
KR1020097016892A KR20090122426A (en) 2007-01-15 2008-01-11 Fusion Proteins Including Tumor Rejecting Antibodies NB-ESO-1 and LAVE-1
MX2009007572A MX2009007572A (en) 2007-01-15 2008-01-11 Fusion protein.
EP08727588A EP2118128B1 (en) 2007-01-15 2008-01-11 Fusion proteins comprising the tumor rejection antigens ny-eso-1 and lage-1
DK08727588.9T DK2118128T3 (en) 2007-01-15 2008-01-11 Fusion proteins comprising the tumor rejection antigens NY-ESO-1 and LAGE-1
BRPI0806501-2A2A BRPI0806501A2 (en) 2007-01-15 2008-01-11 FUSION PROTEIN, NUCLEIC ACID MOLECULE, VECTOR, HOST CELL, VACCIN OR IMMUNOGENIC COMPOSITION, AND USE OF THE FUSION PROTEIN.
PL08727588T PL2118128T3 (en) 2007-01-15 2008-01-11 Fusion proteins comprising the tumor rejection antigens ny-eso-1 and lage-1
HRP20130022AT HRP20130022T1 (en) 2007-01-15 2008-01-11 Fusion proteins comprising the tumor rejection antigens ny-eso-1 and lage-1
ES08727588T ES2398492T3 (en) 2007-01-15 2008-01-11 Fusion proteins comprising the tumor rejection antigens NY-ESO-1 and LAGE-1
PE2008000128A PE20081687A1 (en) 2007-01-15 2008-01-11 FUSION PROTEIN
EA200900738A EA016818B1 (en) 2007-01-15 2008-01-11 Fusion proteins comprising the tumor rejection antigens ny-eso-1 and lage-1
CA002674458A CA2674458A1 (en) 2007-01-15 2008-01-11 Fusion protein
PCT/US2008/050879 WO2008089074A2 (en) 2007-01-15 2008-01-11 Fusion proteins comprising the tumor rejection antigens ny-eso-1 and lage-1
PT87275889T PT2118128E (en) 2007-01-15 2008-01-11 Fusion proteins comprising the tumor rejection antigens ny-eso-1 and lage-1
TW097101220A TW200902049A (en) 2007-01-15 2008-01-11 Fusion protein
AU2008206463A AU2008206463B2 (en) 2007-01-15 2008-01-11 Fusion proteins comprising the tumor rejection antigens NY-ESO-1 and LAGE-1
CNA2008800022234A CN101583623A (en) 2007-01-15 2008-01-11 Fusion protein comprising tumor rejection antigens NY-ESO-1 and LAGE-1
JP2009545705A JP2010532656A (en) 2007-01-15 2008-01-11 Fusion protein containing cancer regression antigens NY-ESO-1 and LAGE-1
SI200830870T SI2118128T1 (en) 2007-01-15 2008-01-11 Fusion proteins comprising the tumor rejection antigens ny-eso-1 and lage-1
CL200800103A CL2008000103A1 (en) 2007-01-15 2008-01-14 FUSION PROTEIN THAT INCLUDES ANTIGENS OF TESTICULAR CANCER OR FRAGMENTS OF THE SAME NY-ESO-1 LINKED WITH LAGE-1, WHERE AT LEAST ONE IS TRUNCATED, OR INCLUDES ONE OR MORE EPITOPES OF NY-ESO-1 OR LAGE-1 ; NUCLEIC ACID THAT CODIFIES IT; COMPO
US12/503,468 US8309096B2 (en) 2007-01-15 2009-07-15 Fusion protein
CY20131100042T CY1113720T1 (en) 2007-01-15 2013-01-14 Fusion Proteins Including NY-ESO-1 Antigens And Volume Disposal LAGE-1

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0700759A GB0700759D0 (en) 2007-01-15 2007-01-15 Novel fusion protein

Publications (1)

Publication Number Publication Date
GB0700759D0 true GB0700759D0 (en) 2007-02-21

Family

ID=37809983

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0700759A Ceased GB0700759D0 (en) 2007-01-15 2007-01-15 Novel fusion protein

Country Status (2)

Country Link
CN (1) CN101583623A (en)
GB (1) GB0700759D0 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110964096B (en) * 2019-12-27 2023-04-21 润方(长春)生物科技有限公司 Preparation method of recombinant human C-reactive protein

Also Published As

Publication number Publication date
CN101583623A (en) 2009-11-18

Similar Documents

Publication Publication Date Title
IL196889A0 (en) Albumin-insulin fusion proteins
IL202128A0 (en) Immunoglobulin fusion proteins
LT3118220T (en) Protein
IL204839A0 (en) Albumin fusion proteins
ZA200908649B (en) Rage fusion proteins
IL205716A0 (en) Formulations for taci-immunoglobulin fusion proteins
LT2144924T (en) Fusion protein vaccine
ZA201000283B (en) Reinigung pegylierter polypeptide
EP1934372A4 (en) Ssb - polymerase fusion proteins
GB0611116D0 (en) Proteins
GB0816976D0 (en) Protein
GB0719231D0 (en) Protein
GB0601976D0 (en) Proteins
GB0725201D0 (en) Peptide fusion proteins
GB0620735D0 (en) Proteins
GB0700759D0 (en) Novel fusion protein
GB0720563D0 (en) Protein
GB0709707D0 (en) Novel fusion protein
GB0715325D0 (en) Fertilisation protein
GB0612443D0 (en) Protein
GB0713169D0 (en) Fusion proteins
GB0612623D0 (en) Proteins
GB0614682D0 (en) Proteins
GB0620304D0 (en) Protein
IL206541A0 (en) Novel protein

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)